Hepatitis C: Resources for Health Professionals
Several resources are available to assist health care professionals in managing hepatitis C.
Below are links to professional guidelines, case reporting requirements and forms, state and national resources for persons living with hepatitis C, and training resources for health care professionals.
COVID-19 impact on Hepatitis C
Learn how the Hepatitis C guidelines are impacted by COVID-19.
- Hepatitis C Guidelines for Local Public Health, P-42134 (PDF)
- Interpretation of Hepatitis C Test Results, Centers for Disease Control and Prevention (CDC) (PDF)
- Hepatitis A, B, and C Summary Table (PDF)
- Hepatitis C in Wisconsin: Increase Among Young People Who Inject Drugs, P-02322 (PDF)
- Managing HIV and Hepatitis C Outbreaks Among People Who Inject Drugs: A Guide for State and Local Health Departments (PDF)
Hepatitis C is a Wisconsin surveillance category II disease. Report to the patient's local health department electronically, through the Wisconsin Electronic Disease Surveillance System (WEDSS), by mail or fax using an Acute and Communicable Disease Case Report Form, F-44151 (MS Word) or by other means within 72 hours upon recognition of a case.
- Communicable Disease Case Reporting Requirements(PDF)
- Case Report Form, F-44151 (PDF)
- Viral hepatitis case report form (PDF)
- Frequently Asked Questions for Health Professionals (CDC)
- Hepatitis C Guidelines for Local Health Departments, P-42134 (PDF)
- Case Reporting and Investigation Protocol (EpiNet): P-02039 Hepatitis C
- Interpretation of Hepatitis C Test Results (CDC) (PDF)
- Hepatitis A, B, and C Summary Table (CDC) (PDF)
- Pharmaceutical Company Patient Assistance and Cost-sharing Assistance Programs: Hepatitis
- Common Patient Assistance Program: Application and Companion Document
Information on how to apply for pharmaceutical assistance programs that offer medicines at little or no cost to eligible patients.
- Wisconsin AIDS/HIV Drug Assistance Program
The Wisconsin AIDS/HIV Drug Assistance Program (ADAP) provides eligible HIV-infected persons access to HIV-related antiretroviral drugs and prophylactic medications. The ADAP drug formulary includes hepatitis C virus (HCV) medications for persons co-infected with HIV and HCV as well as vaccines for hepatitis A and B.
- American Liver Foundation
- CDC – Division of Viral Hepatitis
- CDC Hepatitis Publications and Information Resources
- Combating the Silent Epidemic: US Department of Health and Human Services Action Plan for the Prevention, Care and Treatment of Viral Hepatitis
- Harm Reduction Coalition
- HCV Treatment Guidelines -- American Association for the Study of Liver Disease/Infectious Diseases Society of America
- Immunization Action Coalition
- National Hepatitis Corrections Network
- Viral Hepatitis National Strategic Plan, HHS
- Division of Viral Hepatitis: 2025 Strategic Plan (cdc.gov)
- Wisconsin – Hepatitis C: State of Medicaid Access Report Card
- Hep ElimiNATION: Wisconsin Viral Hepatitis Elimination Report Card
- Hepatitis C in Wisconsin – Summary Report, 2021
- Wisconsin Hepatitis C Virus Surveillance Annual Review, 2021
- Recording and slides from the Wisconsin Hepatitis C Elimination Community Webinar